NCT06734416Not yet recruiting
Evaluation of the Role of Brain Natriuretic Peptide in Acute Coronary Syndrome .
Source: ClinicalTrials.gov · Last updated 16 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The measurements of the natriuretic peptide are useful and beneficial for risk stratification irrespective of the cause during admission time or during hospital stay course. the aim of the study is to Assessment of the role of Brain natriuretic peptide in diagnosis of acute coronary syndrome . Evaluation of the relation of Brain natriuretic peptide to the severity and occurrence of complications in acute coronary syndrome .
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 11 Dec 2024
- Start date
- 1 Jan 2025
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- Assiut University
- Diseases
- Coronary artery disease
- NCT number
- NCT06734416
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Jan 2025 to the primary completion date, 1 Jan 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with previous MI
Other illness
- Patients having renal, liver, malignant, infectious, or inflammatory diseases .
Other
- Eection fraction (EF) less than 30%
- Patients having cardiomyopathy
Who the study is looking for
- patients with acute coronary syndrome.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.